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C. elegans worms hatching in the absence of
food show growth arrest during the first larval
stage (L1). While much has been learned about
the later diapause, dauer, which worms enter
under adverse conditions, much less is known
about the mechanisms governing L1 arrest.
Here we show that worms lacking activity of
the asna-1 gene arrest growth reversibly at the
L1 stage even when food is abundant. asna-1
encodes an ATPase that functions nonautono-
mously to regulate growth. asna-1 is expressed
in a restricted set of sensory neurons and in in-
sulin-producing intestinal cells. asna-1 mutants
are reduced in insulin secretion while overex-
pression of asna-1 mimics the effects of insulin
overexpression. Human ASNA1 is highly ex-
pressed in pancreatic b cells, but not in other
pancreatic endocrine cell types, and regulates
insulin secretion in cultured cells. We propose
that ASNA1 is an evolutionarily conserved mod-
ulator of insulin signaling.
INTRODUCTION
During metazoan development, the growth of different tis-
suesmust be strictly coordinated. One way in which this is
achieved is by the use of systemically acting growth hor-
mones. Since growth is dependent upon the availability
of nutrients, the production or secretion of growth hor-
mones is often responsive to nutrient status. In the past
decade it has become clear that several of the hormones
that were initially identified in mammals also regulate
growth in distantly related organisms such as Drosophila
melanogaster and Caenorhabditis elegans. Studies with
these invertebrates are providing new insights into how
growth is modulated in response to changing nutrient
availability.Postembryonic development in C. elegans in the pres-
ence of abundant nutrients and under other conditions
promoting growth involves four larval stages (L1–L4) and
an adult stage. Reduction in nutrient availability can
have one of several effects, depending upon the stage
at which nutrients become limiting. When eggs hatch in
the absence of food, the L1 larvae that emerge arrest
growth reversibly. They resume normal growth when
food is provided (Johnson et al., 1984). If late L1 or early
L2 larvae are deprived of food, a decision is made not to
progress through the normal (reproductive) life cycle via
the L3 stage, but rather to enter an alternative develop-
mental state, termed dauer, that is adapted for survival un-
der harsh conditions (Albert et al., 1981; Cassada and
Russell, 1975; Li et al., 2003). When L4 worms are de-
prived of food, cell growth is much reduced and the adult
worms they give rise to are much smaller in size.
Normal reproductive growth is promoted by four pairs
of sensory neurons, ASI, ADF, ASG, and ASJ (Bargmann
and Horvitz, 1991). In the presence of abundant food,
and under other conditions conducive to normal growth,
ASI promotes reproductive (nondauer) growth by secret-
ing DAF-28, an insulin-like protein, and DAF-7, a TGFb
pathway ligand. When food becomes scarce, however,
production of DAF-28 and DAF-7 is reduced. DAF-28
acts through a conserved signaling pathway involving
the insulin/IGF1 receptor homolog, DAF-2 (Li et al.,
2003). DAF-28 is also expressed in the posterior intestine
(Li et al., 2003), suggesting that its levels could be regu-
lated in response to altered metabolism in this tissue.
DAF-28 appears to be regulated at the level of both tran-
scription and secretion (Ailion et al., 1999; Li et al.,
2003). However, how nutrient levels are able to affect
the production or secretion of DAF-28 and other insulin-
like proteins is incompletely understood.
Several observations suggest that insulin/IGF1 signal-
ing (IIS) is also involved in regulating L1 arrest. First, a
strong allele of daf-2, e979, causes arrest at the L1 stage
(Gems et al., 1998). Second, overexpression of an inhibi-
tory insulin-like protein, INS-1, in the background of a mu-
tation that reduces daf-2 activity causes L1 arrest (Pierce
et al., 2001). Third, starved L1 larvae with constitutivelyCell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc. 577
active IIS fail to arrest properly (Baugh and Sternberg,
2006; Fukuyama et al., 2006).
The human gene ASNA1 encodes an ATPase ex-
pressed in several tissues of neuroendocrine origin and
especially in the pancreatic islets of Langerhans (Kurdi-
Haidar et al., 1996, 1998). ASNA1 is exceptionally well
conserved during evolution: homologs are present in all
eukaryotes as well as some prokaryotes (Rosen, 1999).
All homologs have a completely conserved DTAPTGHT
motif, and a predicted ATP binding site, GKGGVGKT, in
the Walker A motif. The yeast homolog, Arr4p/Get3p,
has been implicated in vesicle transport (Schuldiner
et al., 2005). Deletion of Arr4p or of the protein with which
it forms a tight complex, Get1p, causes defects in secre-
tion. The localization of the complex changes in response
to nutrient levels: in rich media the complex is present on
the ER, but when cells are moved to minimal media, the
complex moves to the Golgi (Schuldiner et al., 2005) as
well as other vesicular organelles. ASNA1 is essential for
mouse development, but its function in metazoans is not
known (Mukhopadhyay et al., 2006). A C. elegans homo-
log, ASNA-1 (ZK637.5) is predicted to be a 342 amino
acid protein with 54% amino acid sequence identity to
human ASNA1 (Koonin, 1993).
Here we report that C. elegans worms lacking asna-1
activity arrest growth at the L1 stage with reduced IIS.
asna-1::gfp reporters are expressed in some amphid neu-
rons and in the intestine: cells that also express insulin-like
proteins including DAF-28. Increasing asna-1 levels has
the same effect on exit from dauer as that caused by in-
creasing the levels of daf-28. Worms with reduced asna-
1 activity have less secreted DAF-28. asna-1 function
has been conserved in evolution: we show that human
ASNA1 is expressed at high levels in pancreatic b cells
and that it can rescue the C. elegans asna-1 mutant
phenotype. Consistent with the worm results, reducing
or increasing ASNA1 function in mouse insulinoma
cells causes a reduction or increase in insulin secretion,
respectively.
RESULTS
Removal of asna-1 Activity Causes a Reversible
Growth Arrest at the L1 Stage
Injection of asna-1 dsRNA into C. elegans caused the F1
progeny to arrest at the L1 stage even in the presence of
abundant food (Figures 1B and 1C). The arrested animals
were healthy and moved normally. Two observations sug-
gested that the arrest was reversible and not caused by
abnormalities in pattern formation. First, in asna-1(RNAi)
animals left for more than 1 week, the effect of the dsRNA
wore off and the larvae resumed growth to give rise to ap-
parently normal fertile adults. Second, when ASNA1 activ-
ity was provided from a transgene containing a human
ASNA1 cDNA under control of a heat shock promoter,
the L1 arrested larvae resumed growth following heat
shock (Figure 1C). Inspection of the arrested L1 larvae un-
der high magnification revealed that most had arrested578 Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc.approximately midway through the L1 stage, similar to
daf-2(e979) animals. In most animals, the P cells had mi-
grated from their ventro-lateral positions into the ventral
cord. The progenitors of the somatic gonad, Z1 and Z4,
had undergone either one or two rounds of division. The
arrested worms showed no apparent developmental de-
fects in the nervous system, musculature, gonad, intes-
tine, or hypodermis.
Since RNAi sometimes does not cause complete loss of
gene activity, we isolated worms harboring a germline de-
letion mutation in the gene sv42 (Figure 2). The sv42muta-
tion deletes a 1053 bp region spanning the last exon of the
upstream gene ZK637.4, the entire asna-1 promoter, and
502 bp of the coding region. A second mutation, ok938,
obtained from the C. elegans gene knockout consortium,
deletes 1125 bp and terminates 7 bp beyond the stop co-
don (Figure 2). No ASNA-1 protein was detected in worms
homozygous for either sv42orok938 (Figure 2), suggesting
that thesealleles strongly reduceor eliminategene activity.
The asna-1(sv42) phenotype appears to be caused by
the deletion of asna-1 rather than that of ZK637.4. First,
the phenotype of asna-1(sv42) is indistinguishable from
that caused by asna-1(ok938); second, RNAi against
ZK637.4 did not give any obvious mutant phenotype;
third, the phenotypes caused by either sv42 or ok938
were rescued by a transgene containing just the asna-1
gene (Figure 1B). Homozygous sv42 or ok938 animals
segregating from heterozygous mothers all grew up to
be scrawny, sterile adults that were thinner than their
wild-type siblings (n > 1000) (Figure 1B). The homozygous
mutants were noticeably smaller from the L2 stage on-
ward, but became adults at the same time as their wild-
type siblings. The ability of the mutants to evade arrest
at the L1 stage is the result of maternal rescue. asna-1 an-
imals depleted of both maternal and zygotic activity (m-z-)
by asna-1 RNAi of mutant heterozygotes invariably ar-
rested as L1 larvae that failed to resume growth even
when left for longer periods of time (>1week, n = 359). Ma-
ternally rescued asna-1 worms did not show defects in
pattern formation and appeared to contain the wild-type
number of somatic cells. Vulval development, for exam-
ple, was normal.
L1 larvae that are unable to feed because of defects in
the feeding organ, called the pharynx, fail to initiate growth
in the presence of food (Avery, 1993; Figure 3 and data not
shown). Several observations, however, indicate that this
is not the cause of the arrest of asna-1(m-z-) larvae. Pha-
ryngeal pumping was normal (see Figure S1 in the Supple-
mental Data), arrested animals had bacteria in their intes-
tines, and they were able to ingest fluorescent 0.2 mm
diameter beads at a normal rate (Figure S1). The arrest
is also not caused by an inability to take up nutrients into
the intestine by endocytosis. The endocytosis marker
FM4-64 was taken up into the intestine even in L1 arrested
asna-1mutants (Figure S1). L1 arrested worms fed bacte-
ria expressing unc-22 dsRNA showed the twitching phe-
notype that indicates that intestinal cells could take up
and secrete dsRNA.
Figure 1. asna-1 Phenotypes and Nonautonomy of Function
(A) Micrographs of L1 worms viewed with Nomarski differential inter-
ference contrast (DIC) optics. Scale bars are 25 mm. (AA) Wild-type
(N2) hatched in the absence of food. (AB–AD) asna-1(RNAi), asna-
1(ok938) subjected to RNAi, and daf-2(e979) hermaphrodites hatched
in the presence of food. Loss of asna-1 function causes growth arrest
at the L1 stage.
(B) (BA–BE). Adult hermaphrodites (24 hr post molt) viewed under the
dissecting microscope. Scale bars are 250 mm. (BA) Wild-type (N2).
(BB) asna-1(sv42) and asna-1(ok938) adults of the same age. (BC)
asna-1(ok938): svIs56 hermaphrodite. svIs56 is a transgene array con-
taining asna-1::gfp under the control of the asna-1 promoter. (BD)
asna-1(sv42); svEx439 hermaphrodite. svEx439 is a transgene array
containing asna-1::gfp under the control of the elt-2 promoter, which
is specifically expressed in the intestine. (BE) asna-1(sv42); svEx412asna-1::gfp Reporters Are Expressed in Cells
that Express DAF-28 and Other INS Proteins
From computer analysis of the DNA sequence in the re-
gion, asna-1 has been predicted to be the fourth gene in
an operon together with the genes ZK637.2, ZK637.3,
and ZK637.4 (http://ws160.wormbase.org/). We fused
gfp to the last codon of asna-1 and generated worms in
which expression of the fusion gene was driven by se-
quences spanning both asna-1 and the genes lying up-
stream. In worms carrying the transgene, GFP expression
was seen in a subset of sensory neurons, in the intestine,
and, more weakly, in the hypodermis. The distance be-
tween the end of ZK637.4 and the start of asna-1, at 430
bp, is more than four times the usual distance between
genes in operons. Therefore, we tested whether the 430
bp fragment alone was sufficient to rescue the asna-1 de-
fects. Indeed, an ASNA-1::GFP fusion protein driven by
the 430 bp fragment fully rescued asna-1(sv42) and
asna-1(ok938) (Figure 1). In worms carrying the transgene,
like those harboring the longer construct, GFP expression
was seen in a restricted set of sensory neurons, in the in-
testine, and weakly in the hypodermis (Figure 1 and data
not shown). Further analysis of the sensory neuron ex-
pression revealed that during the L1 and L2 stages, GFP
was invariably expressed in ASI, and often also in ASK.
In some animals, expression was also seen in ADL; how-
ever, in most animals expression was not seen in all three
pairs of neurons simultaneously. These data are consis-
tent with SAGE analysis that also indicates that ASNA-1
is expressed in the gut, in sensory neurons, and in the hy-
podermis (http://ws160.wormbase.org/). In addition, the
SAGE data indicate that besides the neurons we have
identified, ASNA-1 may also be expressed in other sen-
sory neurons, including AFD and ASER.
asna-1 Is Required Cell-Nonautonomously
for Growth
To understand further how asna-1 acts to regulate growth,
we tested whether asna-1 was required autonomously or
nonautonomously. We tested the ability of asna-1 under
the control of tissue-specific promoters to rescue the
growth defect. 3/3 transgenes with asna-1::gfp under the
control of the osm-6 promoter (Posm-6), which is expressed
specifically in ciliated sensory neurons (Collet et al., 1998),
and 3/3 transgenes in which asna-1 expression was driven
hermaphrodite. svEx412 is a transgene array containing asna-1::gfp
under the control of the osm-6 promoter, which is specifically ex-
pressed in ciliated sensory neurons. (BF) Wild-type (N2) adult worm
harboring the svEx412 array viewed with both Nomarski DIC and fluo-
rescence optics. The ASNA-1::GFP fusion protein is detectable in sen-
sory neuron cell bodies (arrow) and axons (arrowheads), but not in
other tissues.
(C) Graph showing the proportion of animals arresting at the L1 stage.
RNAi for asna-1 was carried out by injecting dsRNA into an adult her-
maphrodite. % L1 arrest refers to the proportion of the progeny of the
injected animal that were arrested. hs-ASNA1 indicates a transgene
array, svEx121, carrying a human ASNA1 cDNA under the control of
a C. elegans heat shock-responsive promoter.Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc. 579
by the elt-2 promoter, which is expressed specifically in
the intestine (Fukushige et al., 1998), rescued the asna-1
body size phenotype to the same extent as a transgene
containing asna-1 under the control of its own promoter
(Figure 1B). To complement these experiments with heter-
ologous promoters, we performed genetic mosaic analy-
sis. 6/6 mosaic individuals lacking asna-1 activity in the
AB lineage, but being asna-1(+) in the P1 lineage (from
which the intestine is derived) were fully rescued for the
growth defect, implying that asna-1 is not required in all
cells for growth. 5/5 mosaics that were asna-1() in P1,
but asna-1(+) in AB (from which most sensory neurons
are derived), were substantially rescued, although they
were not as big as wild-type.
asna-1 Is a Positive Regulator of the Insulin Pathway
The pathway activated by DAF-2 controls entry into dauer
by regulating the subcellular localization of the forkhead
family transcription factor DAF-16 (Lin et al., 1997; Ogg
et al., 1997; Ogg and Ruvkun, 1998; Paradis and Ruvkun,
1998). In reproductively growing animals, in which IIS is
high, DAF-16::GFP is cytoplasmic, whereas in animals
Figure 2. asna-1 Gene Structure and Deletion Alleles
(A) (From top to bottom) Scale bar, followed by exon/intron structure of
asna-1. Boxes represent exons. The start ATG is indicated by an arrow.
wa and wb denote the regions encoding the Walker A and Walker B
motifs, respectively. The lines below denote the regions of the gene
deleted in the sv42 and ok938 alleles. (Below) GFP fusion constructs
used in this study. pVB214GK contains gfp under the control of the
asna-1 promoter. pVB222GK encodes GFP fused to the last amino
acid of full-length ASNA-1.
(B) Western blot of totalC. elegans protein extracts probed with an an-
tibody raised against ASNA-1 (top), stripped, and reprobed with an
anti-b-tubulin antibody (bottom), to control for protein loading.580 Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc.with reduced IIS, it is found predominantly in the nucleus
(Henderson and Johnson, 2001; Lee et al., 2001; Lin
et al., 2001). In starved L1 larvae, DAF-16::GFP is nuclear
(Baugh and Sternberg, 2006). In 25% (n = 20) of asna-
1(sv42) adults, DAF-16::GFP was nuclear (Figure 4) (cf.
0% for well-fed asna-1(+) animals, n > 100). Nuclear
DAF-16::GFP was also seen in 82% (n = 11) of L1 arrested
asna-1(RNAi) animals. Thus, reduced asna-1 activity is as-
sociated with translocation of DAF-16::GFP to the nucleus
and lowered IIS.
To investigate further the effect of reducing asna-1 ac-
tivity on IIS, we examined the ability of asna-1 mutations
to enhanceDaf-c phenotypes caused bymutations affect-
ing entry into dauer. DAF-7 TGFb controls entry into dauer
Figure 3. ASNA1 Is Expressed in Cells that Produce Insulin or
Insulin-Like Proteins in Humans and C. elegans
(A and C). Micrographs of worms of the genotype svIs56 viewed with
Nomarski DIC optics. svIs56 is a transgene array containing full-length
asna-1::GFP under the control of the asna-1 promoter. Arrows in (C) in-
dicate the position of the intestine. (B and D). Micrographs of the same
worms viewed with fluorescence optics. Scale bars are 25 mm. The
amphid neurons ASI and ASK are indicated. Arrow in (D) indicates cells
expressing the fusion protein. (E–H) Micrographs of human pancreatic
tissue viewed with fluorescence optics (E and F) or light optics (G and
H) at 403magnification. (F and H) Tissue stained with an antibody rec-
ognizing human insulin. (E and G) Tissue stained with an antibody rec-
ognizing human ASNA1. The arrows indicate cells expressing insulin
and ASNA1. The arrowheads indicate other pancreatic islet cells that
express neither insulin nor ASNA1. (G) and (H) show consecutive thin
sections; the regions stained brown (indicated by arrows) are those ex-
pressing insulin and ASNA1, respectively.
by regulating a signal transduction pathway involving the
coreceptors DAF-1 and DAF-4 and the SMAD proteins
DAF-14 and DAF-8 (Patterson and Padgett, 2000). The
TGFb and IIS pathways function in parallel to regulate en-
try into dauer. Mutations in genes in the TGFb and IIS
Figure 4. Effects of Increasing or Decreasing asna-1 Activity
(A) (AA and AB)Micrographs of L1 worms containing an integrated daf-
16::GFP transgene array (Henderson and Johnson, 2001) viewed with
fluorescence optics. The DAF-16::GFP fusion protein is predominantly
cytoplasmic in well-fed worms with high levels of IIS, but is predomi-
nantly nuclear in animals with reduced IIS. (AA) Well-fed asna-1(+)
worm. (AB) Well-fed asna-1(sv42) mutant worm. DAF-16::GFP is pre-
dominantly nuclear in the asna-1mutant background. (AC–AF). Micro-
graphs of worms viewed under the dissecting microscope. The scale
bars are 250 mm. (AC) daf-7(e1372) dauer larval worm grown at
25C. Worms of this genotype that are otherwise wild-type never exit
dauer at this temperature. (AD) daf-7(e1372) adult animal of the
same age expressing elevated levels of ASNA-1 from the integrated
transgene array svIs56. Increased levels of ASNA-1 allow daf-
7(e1372) animals to exit dauer at 25C. (E) asna-1(ok938); unc-
31(e928) double mutant dauer larva raised at 25C. (F) unc-31(e928)
single mutant adult worm raised at 25C. asna-1(ok938) enhances
the dauer phenotype of unc-31(e928) at 25C.
(B) Western blot of totalC. elegans protein extracts probed with an an-
tibody raised against ASNA-1 (top), stripped, and reprobed with an an-
tibody against b-tubulin (bottom) to control for protein loading. svIs54
and svIs56 are two integrated transgenes containing full-length asna-
1::gfp. The positions of endogenous ASNA-1 and the ASNA-1::GFP
proteins are indicated.pathways show synergistic effects, such that double
mutants in which activity of both pathways is partially
reduced enter dauer under conditions in which single
mutants progress through the reproductive life cycle (Ogg
et al., 1997; Thomas et al., 1993). Like those of daf-2,
asna-1 mutations enhanced the Daf-c phenotype caused
by daf-7 at semipermissive temperatures. At 20C only
2% of daf-7(e1372) single mutant worms entered dauer
(n = 230), whereas 100% of daf-7(e1372) asna-1 double
mutant worms did so (n = 340). asna-1 mutations (and
asna-1 RNAi) also enhanced the Daf-c phenotype caused
by a null mutation in unc-31 (Avery et al., 1993). unc-31 en-
codes a homolog of CAPS, a component of dense core
vesicles, which mediate the release of insulin from b cells
in mammals (Berwin et al., 1998). unc-31 mutations pro-
mote entry into dauer at 27C (Ailion et al., 1999). Only
0.2% of unc-31(e928) single mutant worms entered dauer
at 25C (n = 662), whereas 34.2% (n = 105) and 37.5% (n =
122) of asna-1(sv42); unc-31(e928) and asna-1(ok938);
unc-31(e928) double mutants, respectively, did so (Fig-
ure 4). Loss of asna-1 activity also enhanced the Daf-c
phenotype caused by other mutations, including those in
daf-11, daf-14, and daf-8 (see Table S2 in the Supplemen-
tal Data). Thus, reduction in asna-1 activity, like reduced
IIS, can enhance the Daf-c phenotype caused by muta-
tions that compromise signaling between the amphid neu-
rons and target tissues. Taken together these findings
suggest that asna-1 is a positive regulator of IIS.
Overexpression of daf-28 or ins-4 Promotes
Exit from Dauer, and Overexpression
of asna-1 Mimics Their Effects
IIS not only modulates entry into dauer, but is also pro-
posed to play a role in promoting exit from dauer (Tissen-
baum et al., 2000). The muscarinic receptor agonists pilo-
carpine and arecoline stimulate worms with defective
TGFb signaling to exit dauer. It was proposed that these
drugs affect dauer exit by stimulating the release of insu-
lin-like proteins that can bypass the requirement for
TGFb signaling (Tissenbaum et al., 2000). Since this phe-
notype could be used to test the consequences of in-
creased IIS, we examined whether the effects of high
gene dosages of daf-28 or ins-4—which can functionally
substitute for daf-28 (Li et al., 2003)—could mimic the ef-
fects of these drugs on dauer exit. At 25C, daf-7(e1372),
daf-7(m62), daf-1(m40), and daf-8(e1393) mutants (which
all exhibit altered TGFb signaling) or daf-2(e1370) (which
exhibit altered IIS signaling) invariably enter dauer and
never exit this state (Riddle et al., 1997). The TGFb path-
way mutants that overexpressed daf-28 or ins-4 entered
dauer, but exited again soon after, whereas daf-2(e1370)
mutants overexpressing ins-4 or daf-28 did not exit dauer
(Table 1). Thus, overexpression of daf-28 or ins-4 can by-
pass the requirement for the TGFb pathway, but not the in-
sulin pathway, for dauer exit. To examine whether asna-1
could have the same effect, we tested the ability of asna-1
overexpression to promote dauer exit. The transgene
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functional ASNA-1::GFP fusion protein (Figure 4). Both ar-
rays bypassed the requirement for the TGFb signaling
pathway, but not that for insulin signaling (Figure 4 and Ta-
ble 1). Constitutive asna-1 expression under the control of
a sensory neuron-specific promoter from the osm-6 gene
also promoted dauer exit (Table 1). Thus, high asna-1 gene
dosage has the same effects on dauer exit as high doses
of daf-28 or ins-4. In the background of tm2308, a daf-28
deletion mutation, asna-1 could still bypass the require-
ment for daf-7; however, it did so less efficiently. daf-7;
svIs54[asna-1(++)]; daf-28 worms exited dauer only after
5 days. daf-7; svIs54[asna-1(++)] worms did so after
Table 1. Elevated Levels of asna-1, daf-28, or ins-4




exit at 25C N
daf-2 none 0 >1000
daf-7 none 0 >1000
daf-1 none 0 >1000
daf-8 none 0 >1000
daf-2 asna-1(++) line 1 0 81
daf-2 asna-1(++) line 2 0 256
daf-7 asna-1(++) line 1 79 312
daf-7 asna-1(++) line 2 84 353
daf-8 asna-1(++) line 1 68 352
daf-8 asna-1(++) line 2 49 237
daf-1 asna-1(++) line 2 82 253
daf-7 Posm-6:asna-1(++) 28 57
daf-7; daf-28 asna-1(++) line 1 89 102
daf-7; daf-28 asna-1(++) line 2 94 97
daf-2 ins-4(++) 0 155
daf-7 ins-4(++) 27 83
daf-1 ins-4(++) 31 51
daf-2 daf-28(++) 0 82
daf-8 daf-28(++) 90 62
Alleles used: daf-2(e1370), daf-7(e1372), daf-8(e1393), daf-
1(m40), and daf-28(tm2308). Transgenes: svIs54 (line 1) and
svIs56 (line 2) were used for asna-1 overexpression. svEx352
was used for ins-4 overexpression, svEx434 for daf-28 over-
expression, and svEx412 for Posm-6:asna-1 overexpression.
For all strains, embryos were collected from parents over
a 6 hr period at 20C, and the parents were then removed.
Presence of nondauer animals (L4s and young adults) was
scored after 96 hr as evidence of dauer exit. For transgenic
daf-2 strains, the plates were screened again after 1 week
to look for any nondauers. For all experiments, plates with
a Daf-c mutant were incubated alongside the experimental
plates to ensure that the temperature was nonpermissive for
dauer exit in the absence of transgenes.582 Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc.3 days. The results of our mosaic analysis, and the fact
that asna-1 driven by the elt-2 intestine-specific promoter
rescued the asna-1 growth defect, suggested that one fo-
cus for asna-1 is in the intestine. We found that daf-28
could also function in the intestine: the transient dauer de-
fect caused by a dominant daf-28 point mutation, sa191,
was partially rescued by wild-type daf-28 driven by the
elt-2 promoter (7%, n = 301). Consistent with this result,
asna-1 driven by the daf-28 promoter fully rescued the
asna-1 growth defect (n R 100). The expression of
ASNA-1::GFP was not reduced in daf-2; svIs54 or daf-2;
svIs56 dauer larvae (data not shown). Together, these re-
sults suggest that ASNA-1 may act by promoting produc-
tion or release of INS proteins.
ASNA-1 Has ATPase Activity In Vitro that Is Required
for Function In Vivo
E. coli ArsA and human ASNA1 both have ATPase activity
in vitro (Karkaria et al., 1990; Kurdi-Haidar et al., 1996). Pu-
rified C. elegans GST::ASNA-1 hydrolyzed ATP in vitro
with a Km of 0.15mM (Figure 5C). The specific ATPase ac-
tivity for GST::ASNA-1 was 33.6 ± 0.9 (n = 8) nmol/min/mg
protein. A transgene bearing an asna-1 construct with
a mutation in the ATP binding site (Karkaria et al., 1990)
that was expressed at levels similar to that of the rescuing
transgenes (Figure 5A) failed to rescue the body size de-
fect of asna-1(sv42) (Figure 5B) and failed to promote
daf-8(e1393) exit from dauer (data not shown). Thus,
ASNA-1 has ATPase activity in vitro, and this activity
appears to be required for function in vivo.
Mammalian ASNA1 Is Expressed in Pancreatic
b Cells and Promotes Insulin Release
To investigate whether ASNA1 was involved in insulin sig-
naling in mammals, we first examined whether ASNA1
was expressed in cells that produce insulin in humans.
Staining with anti-human ASNA1 antibodies (Kurdi-Haidar
et al., 1998) revealed that in the pancreatic islets of Lang-
erhans, ASNA1was highly expressed in b cells (Figure 3B),
but was not detectable in other pancreatic endocrine or
exocrine cell types (data not shown). The dauer exit results
suggested a role for asna-1 either in the production of in-
sulin or its release. To distinguish between these possibil-
ities, we tested the effect of increasing the dose of human
ASNA1 in a mouse insulinoma cell line, NIT-1 (Hamaguchi
et al., 1991). For these experiments, NIT-1 cells were
transfected with a plasmid encoding human ASNA1,
pMS22. Individual clones were isolated and examined
for their expression of ASNA1 protein. The two clones
that produced the highest levels, S10 and S11, were cho-
sen for further analysis. Froma separate transfection, con-
trol clones were established that contained just the empty
plasmid vector, pTarget (Promega, Madison, USA). Both
S10 and S11, which produce approximately twice the nor-
mal levels of ASNA1, secreted significantly higher levels of
insulin into themedia in multiple independent experiments
compared with empty vector-bearing cells (Figure 6). The
increase in insulin levels in the media was not caused by
an increase in insulin production since the total cell con-
tent of proinsulin and insulin was not significantly different
from that in NIT-1-derived clones derived from transfor-
mations with empty vector (Figure 6).
To examine whether reducing ASNA1 activity reduced
the amount of insulin secreted into the media, we gener-
ated clones with constitutively reduced ASNA1 expres-
Figure 5. C. elegans ASNA-1 Has ATPase Activity that Is
Required for Function In Vivo
(A) Diagram of an asna-1::gfp fusion gene (on the plasmid pVB287GK)
containing a deletion (underlined) in the region encoding the ATP bind-
ing domain.
(B) (BA and BB) Micrographs of adult C. elegans worms (24 hr post
molt) viewed under the dissecting microscope at 1003 magnification.
Scale bars are 250 mm. (BA) asna-1(sv42); svIs56 hermaphrodite. The
svIs56 transgene array harbors a wild-type asna-1::gfp fusion gene
that rescues the asna-1 body size defect. (BB) asna-1(sv42); svEx411
hermaphrodite. svEx411 is a transgene array containing pVB287GK
(shown above) that encodes the mutant asna-1::gfp transgene.
svEx411 fails to rescue the body size defect. (BC and BD) svEx411 her-
maphrodite viewed with DIC (BC) or fluorescence (BD) optics at 6303
magnification. The asna-1 phenotype is not rescued even though the
mutant fusion protein is expressed.
(C) ATPase activity of a purified GST::ASNA-1 fusion protein plotted
against ATP concentration. Fifty micrograms of protein were used
for each measurement. Measurements were made in the concentra-
tion range of 0.05–1.6 mM ATP. Km = 0.15 ± 0.04.sion. For these experiments, a plasmid generating anti-
sense ASNA1 transcripts, pMS23, was transfected into
NIT-1 cells and individual clones were selected. Two inde-
pendent clones were generated, AS13 and AS14, in which
the amount of ASNA1 protein was approximately half that
in the parent NIT-1 cells or in clones derived from transfor-
mations with empty vector. Clones with still lower ASNA1
expression were not possible to maintain in culture since
they grew too slowly. The two clones with decreased
ASNA1 levels both had reduced insulin secretion into the
media (Figure 6).
Antisense against a control gene expressed in b cells
did not affect ASNA1 protein levels (Figure S2). We con-
clude that ASNA1 is involved in secretion rather than pro-
duction of insulin. Clones with increased amounts of
ASNA1 could still be stimulated to secrete more insulin
by glucose. In four independent tests, glucose caused
on average a 95% increase in the insulin secreted by the
S10 ASNA1-overexpressing clone. The comparable figure
for a clone generated with empty vector was 96%. Clones
with reduced ASNA1 could also be stimulated to secrete
insulin, although, in this case, the increase was less: glu-
cose caused on average a 26% increase in insulin se-
creted by the ASNA1-underexpressing clone AS14.
C. elegans Worms with Reduced asna-1 Function
Have Less SecretedDAF-28 Ins in the Pseudocoelom
To test whether reduction of asna-1 activity in C. elegans
could affect secretion of insulin, we generated worms
expressing a full-length DAF-28::GFP protein (from
pVB298GK) and observed whether reducing asna-1 func-
tion altered its distribution. In wild-type worms, in addition
to being in the amphid neurons and the gut, the protein is
also found in coelomocytes (Figure 6), scavenger cells that
constitutively endocytose material secreted into the psue-
docoelom (Fares and Greenwald, 2001). In the coelomo-
cytes, the full-length DAF-28::GFP protein was present
in vacuoles that have been shown to take up the endocy-
tosis marker FM4-64 (Fares and Greenwald, 2001). daf-
28::gfp transcriptional reporters are not expressed in
coelomocytes (Li et al., 2003) (G.K., S.T., and P.N., unpub-
lished data). The presence of DAF-28::GFP in coelomo-
cytes, therefore, is the result of uptake of the protein
from the psuedocoelomic fluid rather than that of tran-
scription of daf-28 in these cells. The expression of a
transcriptional DAF-28::GFP protein (from pVB252GK) in
neurons or the intestine was similar to that in wild-type
in asna-1(RNAi) animals, indicating that asna-1 is not re-
quired for the transcription of daf-28 or for the stability of
the fusion protein. However, while wild-type animals ex-
pressing the full-length fusion protein always have GFP-
labeled coelomocytes (n > 150), 20%–45% of the animals
from three independent lines exposed to asna-1(RNAi)
had no GFP-labeled coelomocytes (n = 73). Loss of
asna-1 activity did not affect uptake of a fluid phase endo-
cytosis marker, YP120::GFP, into coelomocytes, implying
that asna-1 is not required for endocytosis in coelomo-
cytes. Together, these observations suggest that lessCell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc. 583
Figure 6. ASNA1 Promotes Insulin Secretion
(A and B) Relative amounts of insulin secreted into the medium by cell
clones derived from themouse insulinoma cell line NIT-1. Mediumwas
glucose-free KRB supplemented with 0.1% BSA. Data given are the
mean ± SEM and were collected as duplicates in four independent ex-
periments. Statistics were calculated using the Mann-Whitney U-test.
*p < 0.05 versus NIT-1 empty vector cells. emv., clone derived by
transformation with empty vector. (A) S11 and S10 are two clones
that express elevated levels of human ASNA1. (B) AS13 and AS14
are two clones that express decreased levels of human ASNA1.
Medium and statistics for (B) were as in (A).
(C) (Top) total insulin and proinsulin content in cell clones expressing
different levels of ASNA1. Clones are those described in (A) and (B).
Medium and statistics were as in (A). Data given are the mean ±
SEM and were collected as duplicates in three independent experi-584 Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc.DAF-28::GFP protein is secreted into the psuedocoelom
when asna-1 function is reduced.
DISCUSSION
Reduction in IIS activity inC. elegans causes entry into the
dauer stage even under conditions conducive to repro-
ductive growth. However, severe perturbations in the
function of DAF-2, the insulin/IGF1 receptor homolog
that regulates entry into dauer, cause arrest at the earlier
developmental stage L1 (Gems et al., 1998). We reasoned
that some genes encoding proteins involved in IIS might
not have been identified in genetic screens performed
previously for those affecting the dauer decision because
mutations in them would cause arrest earlier in develop-
ment. Here we present the results of experiments on
asna-1. Animals lacking asna-1 activity arrest reversibly
at the L1 stage without obvious defects in pattern forma-
tion and have reduced IIS. asna-1::gfp reporter genes
are expressed in a subset of neurons and in the intestine,
tissues that produce insulin-like proteins including DAF-
28. Secretion of DAF-28 into the body cavity is reduced
in worms with decreased asna-1 activity. We show that
overexpression of either daf-28 Ins or ins-4 Ins promotes
exit from dauer and that increasing asna-1 function
mimics the effects of daf-28 and ins-4 in a daf-2 ins/
IGFR receptor-dependent manner. The human homolog
of asna-1 is expressed at high levels in pancreatic b cells,
but not in a or d cells. Furthermore, increasing or reducing
ASNA1 function in mouse insulinoma cells causes an in-
crease or decrease, respectively, in insulin secretion.
In C. elegans L1 larvae hatched in the absence of food,
cells are blocked in the G1 phase of the cell cycle and fail
to divide. If the block on cell division is removed, for exam-
ple by a reduction in the activity of the cell cycle regulator
cki-1, some cell division occurs (Hong et al., 1998). Consti-
tutive activation of IIS causes ectopic cell division within
the germline (Fukuyama et al., 2006). These observations
imply that cells in starved L1 larvae are not inherently un-
able to divide because of a lack of an essential metabolite
required for cell growth or cell division. The fact that muta-
tions in daf-2 ins/IGFR can cause arrest at the L1 stage
strongly suggests that growth arrest ismodulated system-
ically in part by at least one or more insulin-like proteins.
Mutations that cell autonomously block all postembry-
onic cell divisions in C. elegans would likely cause arrest
ments. (Below) Western blot of protein from clones shown above.
Twenty micrograms of total protein was loaded in each lane. (Bottom)
Protein stained with Coomassie to control for equal loading.
(D) Micrographs of worms viewed at 10003magnification with Nomar-
ski DIC (DA and DC) or fluorescence (DB and DD) optics. (DA and DB)
Wild-type (N2) worms harboring the integrated transgene array svIs69.
The transgene contains daf-28::gfp under its endogenous promoter.
(DC and DD) svIs69 hermaphrodites subjected to asna-1 RNAi. cc in
(DA) and (DC) indicates a coelomocyte. The coelomocyte in (DB), but
not that in (DD), accumulates GFP. int, intestine, which is the source
of the autofluorescent granules.
at the L1 stage. It is unlikely, however, that the L1 arrest
seen in worms lacking asna-1 activity reflects a cell auton-
omous requirement for asna-1 in cell division. First, no de-
fects in cell division are seen in embryos lacking asna-1
activity or in larvae lacking zygotic gene activity. Second,
expression of human ASNA1 under the control of tissue-
specific promoters is sufficient to rescue the L1 arrest
defect caused by asna-1(RNAi) (data not shown). Third,
genetic mosaics demonstrate a cell nonautonomous re-
quirement for asna-1 for growth. This cell nonautonomous
requirement for asna-1 suggests instead that asna-1 is re-
quired for the action of one or more hormonal signals that
promote growth. Our observations that IIS is reduced in
asna-1 mutants and that overexpressing asna-1 mimics
the effects of overexpressing insulin-like proteins strongly
suggest that one way in which asna-1 promotes growth is
by modulating the levels of one or more insulin-like pro-
teins. High levels of ins-1, like asna-1(RNAi), cause L1
arrest (Pierce et al., 2001). However, all ins-1(tm1888);
asna-1(RNAi) animals also arrest as L1s (n = 158), implying
that asna-1 cannot act solely by repressing the expression
or activity of ins-1.
We have shown that the ability of asna-1 to stimulate
exit from dauer is dependent upon daf-2 ins/IGFR. Thus,
formally, asna-1 functions upstream of daf-2. Two obser-
vations suggest, however, that although asna-1 is required
for activation of the pathway involving daf-2 in C. elegans,
this is likely not ASNA-1’s only function. First, while the
daf-2 phenotype is fully suppressed by null mutations in
daf-16 FOXO, daf-16(lf) does not suppress the L1 arrest
defect caused by loss of asna-1 activity (G.K., S.T., and
P.N., unpublished data). Second, temperature-sensitive
mutations that reduce IIS cause an increase in life span.
asna-1mutant adults rescued for the L1 arrest bymaternal
gene activity do not have increased life span. These differ-
ences suggest that asna-1’s function is not mediated en-
tirely by daf-16. It is possible that one or more of the INS
proteins function not through DAF-2 but by a different
receptor or receptors that do not act through DAF-16.
A yeast homolog of ASNA-1, Arr4/Get3, has been impli-
cated in membrane trafficking within the secretory path-
way (Schuldiner et al., 2005). However, it is unlikely that
ASNA-1 has a general role in secretion or in other mem-
brane trafficking functions. RNAi with genes encoding
proteins thought to have wide roles in secretion does not
lead to reversible L1 arrest, but instead often causes
a more severe phenotype (Table S3). Yeast cells lacking
Get3 function also do not have nonspecific defects in
secretion (Auld et al., 2006; Schuldiner et al., 2005).
Our results withmammalian cells are consistent with the
possibility that ASNA1 promotes one of the steps leading
to the release of insulin from b cells. For example, ASNA1
could affect the activity of ion channels that regulate the
docking of insulin-bearing dense core vesicles with the
cell membrane in response to an increase in ATP levels.
The fact that ASNA1 is itself an ATPase argues against
a model in which ASNA1 functions by increasing ATP
levels through promoting glycolysis or oxidative phos-phorylation. Themechanism governing the secretion of in-
sulin appears to be conserved in C. elegans (Ailion et al.,
1999). The fact that high asna-1 gene doses mimic the ef-
fects of increasing IIS in promoting exit from dauer implies
that under these conditions asna-1 function in C. elegans
is also rate limiting.
Concluding Remarks
This paper describes the identification of a positive regu-
lator of insulin signaling that has been conserved in evolu-
tion. Genetic screens for mutations that cause reversible
L1 arrest in C. elegans should allow the identification of
proteins with which ASNA-1 acts as well as other factors
involved in nutrient-dependent growth control in the
worm. Given the degree of conservation of the mecha-
nisms governing insulin release and those by which insulin
and insulin-like proteins function, it seems probable that
other genes involved in regulating L1 arrest will, like
ASNA1, prove to have similar roles in mammals. Both
ASNA1 and the proteins with which it acts are potential
targets for drugs for the treatment of human diseases
associated with defects in insulin metabolism.
EXPERIMENTAL PROCEDURES
C. elegans Techniques
Handling of C. elegans strains was as described (Brenner, 1974).
Experiments were carried out at 20C unless otherwise stated. N2 is
the wild-type parent for all strains used in this study. Injection RNAi
and feeding RNAi were done as described (Fire et al., 1998). sv42
was isolated from a frozen deletion library (Kao et al., 2004). The exter-
nal primers were ACGTCCTTTTGGCACGCATC and ACGAGTCGGCT
CTACGTCAC. The internal primers were ACAGCTGCGGTGTGTG
TTTC and CGCTCCAAATGGGAACGACG. The sv42 and the ok938
mutants were backcrossed to N2 seven times before use.
Plasmids
Plasmids used in this experiment are as follows:
pVB190GK: asna-1 cDNA cloned into feeding RNAi plasmid
L4440.
pBV202GK: Pasna-1::hASNA1.
pVB214GK: Pasna-1::asna-1::GFP. GFP fused to the 8
th codon of
asna-1.
pVB222GK: Pasna-1::asna-1::GFP. GFP fused to the last codon of
asna-1.
pVB252GK: Pdaf-28::daf-28::GFP. GFP fused to the 7
th codon of
daf-28.
pVB275GK: Pelt-2::asna-1. Injected at 100 ng/ml.
pVB281GK: ins-4 genomic fragment (Li et al., 2003).
pVB288GK: daf-28 genomic fragment driven by its own promoter.
pVB287GK: Same as pVB222GK except for a 12 bp deletion in the
Walker A motif that preserves the reading frame.
pVB298GK:: Pdaf-28::daf-28::GFP. GFP fused to the last codon of
daf-28.
pVB308GK:: Posm-6::asna-1::GFP. GFP fused to the last codon of
the asna-1 cDNA. Injected at 50 ng/ml.
Plasmid construction details are provided in the Supplemental Data.
ATPase Assay of GST::ASNA-1 Fusion Protein
GST::ASNA-1 protein was purified from E. coli BL21 cells containing
the full-length asna-1 cDNA cloned into pGEX-5X-2 by following
the manufacturer’s instructions (Amersham). ATPase activity wasCell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc. 585
determined at room temperature using a standard assay in which ATP
hydrolysis is coupled to the oxidation of NADH (Vogel and Steinhart,
1976). The decrease in NADH concentration was monitored spectro-
photometrically at 340 nm. The reaction buffer was 50 mM Hepes
(pH 7.5), 30 mMKCl, 5 mM ATP, 4 mM phosphoenol pyruvate, 6 U lac-
tate dehydrogenase, and 0.2mMNADH, and the volumewas 1ml. The
reaction was initiated by adding 5 mM MgCl and monitored for 15–20
min. The linear steady state rates between 5 and 10 min were used to
calculate the specific activity at 340 nm.
Antibodies and Western Blots
Rabbit anti-worm ASNA-1 polyclonal antibodies were generated by
immunizing animals with recombinant worm GST-ASNA-1 fusion pro-
tein (Agrisera, Sweden). The antibodies, used at 1:2000 dilution, detect
a single 42 kDa protein band on western blots of worm lysates.
Pancreatic Tissues
Formalin-fixed and paraffin-embedded samples of normal human pan-
creas were obtained from patients who had undergone surgery at the
Department of Surgery, Umea˚ University Hospital. The study was
approved by the ethical committee at Umea˚ University.
Human Pancreas Tissue Staining
ASNA1 was detected in formalin-fixed paraffin-embedded human
pancreas tissue sections with the mouse antibody 5G8 (Kurdi-Haidar
et al., 1998). The sections were deparaffinized in xylene, rehydrated in
ethanol, and treated with 5% Pronase in Tris-buffered saline (pH 7.2)
for 18 min. Endogenous peroxidase activity was quenched with
absolute methanol/3% H2O2 for 20 min. Nonspecific binding was
blocked with 10% horse serum in PBS for 30 min. The sections were
incubated overnight in a moist chamber at 4C with 5G8 diluted 1:50
in blocking solution. Insulin was detected by an anti-insulin antibody
diluted 1:50,000 (Sigma). The Vector Elite ABC kit and biotinylated sec-
ondary antibodies (Vector Labs) were used to detect the primary anti-
bodies with AEC chromogen. Slides were counterstained in hematox-
ylin. For immunoflorescence double-staining, a fluorescein anti-mouse
IgM secondary antibody (Vector Labs) was used to detect 5G8 and
a Texas red anti-mouse IgG secondary antibody (Vector Labs) was
used to detect the anti-insulin primary antibody.
NIT-1 Cell Culture and Generation of Clones
NIT-1 cells, a clonal NOD/Lt mouse insulinoma line (Hamaguchi et al.,
1991), were maintained in culture in F-12Kmedia (Gibco Labs) supple-
mented with 10% fetal calf serum (FCS). NIT-1 clones expressing in-
creased or decreased levels of ASNA1 were generated by introducing
plasmids containing a human ASNA1 cDNA in the sense or antisense
orientation under the control of a constitutively active Cytomegalovirus
(CMV) promoter. Transfections were performed with the aid of lipofec-
tamin (Life Technologies). Transformants were selected in complete
medium containing 1 mg/ml G418 (Gibco Labs). After 3–4 weeks, sin-
gle and independent cell clones were randomly isolated, and each
individual clone was plated separately. After clonal expansion, cells
were maintained in complete medium containing 0.3 mg/ml G418.
Insulin Secretion Experiments
NIT-1 wild-type, empty vector, sense ASNA1, and antisense ASNA1
plasmid bearing cells were grown in T25 cellular flasks, transferred
to a 6-well plate, and cultured overnight to 60%–70% confluence.
The cells were washed twice with glucose-free KRB (Krebs Ringer Bi-
carbonate) and then exposed to KRB with 0.1% BSA for 2 hr at 37C.
The medium was then collected and centrifuged at 900 rpm for 5 min.,
and the supernatant was saved for insulin measurements. Proinsulin/
insulin concentration was measured with a rat RIA kit (RI-13K, Linco
Research Inc). After removal of the medium, the cells were washed
and lysed. The amount of protein in the cell lysates was measured.
For experiments with glucose, KRB-BSA media containing 3 mg/ml
(16.7 mM) glucose was used in place of glucose-free KRB.586 Cell 128, 577–587, February 9, 2007 ª2007 Elsevier Inc.Supplemental Data
The Supplemental Data for this article can be found online at http://
www.cell.com/cgi/content/full/128/3/577/DC1/.
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